News

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...
Ghana recorded 15,290 new HIV infections with 12,614 AIDS related deaths in 2024, according to data from the National and Sub National HIV and AIDS Estimates and Projections. Of the total infections, ...
To explore this, the researchers performed several assays using peripheral blood mononuclear cells (PBMC) from people living with HIV who either received ART less than 1.5 months following HIV ...
New York State Assemblymember Zohran Mamdani, 33, shocked political observers with his likely upset of former Gov. Andrew ...
There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...
Professor Thumbi Ndung'u and his team at the Africa Health Research Institute are pioneering a study that explores innovative treatments for HIV, aiming to reduce reliance on lifelong ...
Drawing from 19 studies across sub-Saharan Africa and select global contexts, the review finds that RHIS remain largely ...
Utah biochemist Wesley Sundquist has achieved yet another milestone with the Food and Drug Administration approval of an ...
Patients with HIV receiving 3-drug ART with BIC/FTC/TAF exhibited low rates of viremia, particularly those with high treatment adherence.
Elevated immune and neuronal injury markers in MSM with HIV and PrEP suggest lifestyle factors, beyond HIV, drive persistent ...
LA CAB plus RPV effectively maintained virologic suppression among patients with infection in real-world clinical practice.
Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...